Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning systemic manifestations and novel therapeutics in psoriasis, real-world outcomes in hair restoration, and emerging safety and diagnostic data in inflammatory dermatoses. Let's dive in. [PAUSE] We begin with a deep look at psoriasis as a systemic disease and the potential for deep immunological resetting. In t…

This week's papers:

Efficacy and safety of inhibitory magnetic stimulation in the treatment of refractory erythema of rosacea: a prospective, randomized, controlled clinical trial. — Journal of the American Academy of Dermatology 2026
Long-term Real-world Outcomes and Tolerability of Baricitinib in Alopecia Areata, Totalis, and Universalis: A Retrospective Single-center Cohort of 330 Patients with Trichoscopy Monitoring. — Journal of the American Academy of Dermatology 2026
Increased Efficacy of Daytime Low-dose Oral Minoxidil Dosing for Androgenetic Alopecia: A Retrospective Study. — The British journal of dermatology 2026
Cardiac structure and function in psoriasis: A cross-sectional analysis of the PSOCADIA study. — Journal of the European Academy of Dermatology and Venereology 2026
Malignant transformation in mucosal lichen planus: A 10-year, single-center, descriptive cohort analysis. — Journal of the American Academy of Dermatology 2026
Pemphigoid was not associated with increased risk of solid organ, hematologic, or nonmelanoma skin malignancies in a nationally representative matched cohort. — Clinical and experimental dermatology 2026
Relapse prediction in rituximab-treated pemphigus patients: A prognostic model. — Journal of the European Academy of Dermatology and Venereology 2026
Effect of semaglutide on hidradenitis suppurativa disease control and quality of life: A case series. — Journal of the European Academy of Dermatology and Venereology 2026
Missed melanoma following skin lesion triage by an autonomous artificial intelligence system in a community setting. — Clinical and experimental dermatology 2026
Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma. — Clinical and experimental dermatology 2026